264 related articles for article (PubMed ID: 25144611)
1. Metformin and gynecologic cancers.
Stine JE; Bae-Jump V
Obstet Gynecol Surv; 2014 Aug; 69(8):477-89. PubMed ID: 25144611
[TBL] [Abstract][Full Text] [Related]
2. mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review.
Husseinzadeh N; Husseinzadeh HD
Gynecol Oncol; 2014 May; 133(2):375-81. PubMed ID: 24556063
[TBL] [Abstract][Full Text] [Related]
3. Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin.
Goodwin PJ; Stambolic V
Breast; 2011 Oct; 20 Suppl 3():S31-5. PubMed ID: 22015290
[TBL] [Abstract][Full Text] [Related]
4. [Metformin--new treatment strategies for gynecologic neoplasms].
Milewicz T; Kiałka M; Mrozińska S; Ociepka A; Krzysiek J
Przegl Lek; 2013; 70(2):81-4. PubMed ID: 23879009
[TBL] [Abstract][Full Text] [Related]
5. Old drug, new trick: repurposing metformin for gynecologic cancers?
Febbraro T; Lengyel E; Romero IL
Gynecol Oncol; 2014 Dec; 135(3):614-21. PubMed ID: 25455733
[TBL] [Abstract][Full Text] [Related]
6. Metformin: taking away the candy for cancer?
Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
[TBL] [Abstract][Full Text] [Related]
7. Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials.
Liu Y; Qin A; Li T; Qin X; Li S
Gynecol Oncol; 2014 Jun; 133(3):647-55. PubMed ID: 24736024
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for gynecologic cancers occurring during pregnancy.
Ko EM; Van Le L
Obstet Gynecol Surv; 2011 May; 66(5):291-8. PubMed ID: 21794193
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis.
Zhang ZJ; Li S
Diabetes Obes Metab; 2014 Aug; 16(8):707-10. PubMed ID: 24460896
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
Guppy A; Jamal-Hanjani M; Pickering L
Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
[TBL] [Abstract][Full Text] [Related]
11. The impact of obesity on the incidence and treatment of gynecologic cancers: a review.
Modesitt SC; van Nagell JR
Obstet Gynecol Surv; 2005 Oct; 60(10):683-92. PubMed ID: 16186785
[TBL] [Abstract][Full Text] [Related]
12. Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.
Gadducci A; Biglia N; Tana R; Cosio S; Gallo M
Crit Rev Oncol Hematol; 2016 Sep; 105():73-83. PubMed ID: 27378194
[TBL] [Abstract][Full Text] [Related]
13. Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.
Mitsuhashi A; Kiyokawa T; Sato Y; Shozu M
Cancer; 2014 Oct; 120(19):2986-95. PubMed ID: 24917306
[TBL] [Abstract][Full Text] [Related]
14. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
Muggia FM
Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530
[TBL] [Abstract][Full Text] [Related]
15. Physical activity and gynecologic cancer prevention.
Cust AE
Recent Results Cancer Res; 2011; 186():159-85. PubMed ID: 21113764
[TBL] [Abstract][Full Text] [Related]
16. Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.
Duenas-Gonzalez A; Medina-Franco JL; Chavez-Blanco A; Dominguez-Gomez G; Fernández-de Gortari E
Expert Opin Pharmacother; 2016; 17(3):323-38. PubMed ID: 26559668
[TBL] [Abstract][Full Text] [Related]
17. Rational study endpoints in anti-neoplastic agent regulatory approval trials in the gynecologic malignancies.
Markman M
Womens Health (Lond); 2016 Jul; 12(4):396-9. PubMed ID: 27638892
[TBL] [Abstract][Full Text] [Related]
18. Metformin is associated with improved survival in endometrial cancer.
Ko EM; Walter P; Jackson A; Clark L; Franasiak J; Bolac C; Havrilesky LJ; Secord AA; Moore DT; Gehrig PA; Bae-Jump V
Gynecol Oncol; 2014 Feb; 132(2):438-42. PubMed ID: 24269517
[TBL] [Abstract][Full Text] [Related]
19. Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?
Shafiee MN; Khan G; Ariffin R; Abu J; Chapman C; Deen S; Nunns D; Barrett DA; Seedhouse C; Atiomo W
Gynecol Oncol; 2014 Jan; 132(1):248-53. PubMed ID: 24183733
[TBL] [Abstract][Full Text] [Related]
20. Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH).
Engel JB; Schally AV; Buchholz S; Seitz S; Emons G; Ortmann O
Arch Gynecol Obstet; 2012 Aug; 286(2):437-42. PubMed ID: 22555802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
